Management of inadequate response and adverse effects to dupilumab in atopic dermatitis
Author:
Publisher
Elsevier BV
Subject
Dermatology
Reference66 articles.
1. Dupilumab for Atopic dermatitis: the silver bullet we have been searching for?;Tameez Ud Din;Cureus,2020
2. Two phase 3 trials of dupilumab versus placebo in atopic dermatitis;Simpson;N Engl J Med,2016
3. Efficacy and safety of dupilumab in adolescents with uncontrolled moderate to severe atopic dermatitis: a phase 3 randomized clinical trial;Simpson;JAMA Dermatol,2020
4. Efficacy and safety of dupilumab with concomitant topical corticosteroids in children 6 to 11 years old with severe atopic dermatitis: a randomized, double-blinded, placebo-controlled phase 3 trial;Paller;J Am Acad Dermatol,2020
5. Real-world evidence of dupilumab efficacy and risk of adverse events: a systematic review and meta-analysis;Halling;J Am Acad Dermatol,2021
Cited by 60 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. A γδ T cell–IL-3 axis controls allergic responses through sensory neurons;Nature;2024-09-04
2. IL-22 in Atopic Dermatitis;Cells;2024-08-22
3. Biologic and Small Molecule Therapy in Atopic Dermatitis;Biomedicines;2024-08-13
4. Dupilumab facial dermatitis in atopic dermatitis patients ameliorated by topical crisaborole: An open‐label case series study;Journal of the European Academy of Dermatology and Venereology;2024-08-06
5. Therapeutic Potential and Mechanisms of Mesenchymal Stem Cell and Mesenchymal Stem Cell-Derived Extracellular Vesicles in Atopic Dermatitis;Journal of Inflammation Research;2024-08
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3